Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Feb;21(2):155–163. doi: 10.1111/j.1365-2125.1986.tb05170.x

Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

L Aarons, R Salisbury, M Alam-Siddiqi, L Taylor, D M Grennan
PMCID: PMC1400914  PMID: 3954931

Abstract

Clinical assessment, plasma and synovial fluid kinetics were studied in 29 rheumatoid patients receiving 100 mg flurbiprofen twice daily. Clinical assessment and pharmacokinetic measurements varied widely within the group of patients. The average values for plasma clearance, volume of distribution and elimination halflife of flurbiprofen were 0.65 +/- 0.24 ml min-1 kg-1, 0.160 +/- 0.093 l kg-1 and 3.1 +/- 1.7 h, respectively. Synovial fluid drug concentrations peaked later and were lower than corresponding plasma concentrations: 5.2 h and 4.4 mg l-1 as against 1.49 h and 12.5 mg l-1, respectively. At 48 h after an oral dose of flurbiprofen, all the drug had been cleared from the synovial fluid. Synovial fluid drug concentrations were not related to synovial fluid albumin concentration or pH. There was a weak relationship between synovial fluid drug concentration and the thermographic measurements of disease activity. The fractions of flurbiprofen not bound to protein in synovial fluid and plasma were not significantly different. A simple model is proposed to account for the plasma and synovial fluid pharmacokinetics.

Full text

PDF
163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons L., Grennan D. M., Siddiqui M. The binding of ibuprofen to plasma proteins. Eur J Clin Pharmacol. 1983;25(6):815–818. doi: 10.1007/BF00542526. [DOI] [PubMed] [Google Scholar]
  2. Aarons L., Khan A. Z., Grennan D. M., Alam-Siddiqi M. The binding of flurbiprofen to plasma proteins. J Pharm Pharmacol. 1985 Sep;37(9):644–646. doi: 10.1111/j.2042-7158.1985.tb05101.x. [DOI] [PubMed] [Google Scholar]
  3. Adams S. S., Burrows C. A., Skeldon N., Yates D. B. Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen. Curr Med Res Opin. 1977;5(1):11–16. doi: 10.1185/03007997709108969. [DOI] [PubMed] [Google Scholar]
  4. Bird H. A., Ring E. F., Bacon P. A. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann Rheum Dis. 1979 Feb;38(1):36–39. doi: 10.1136/ard.38.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs. 1979 Dec;18(6):417–438. doi: 10.2165/00003495-197918060-00001. [DOI] [PubMed] [Google Scholar]
  6. Cardoe N., de-Silva M., Glass R. C., Risdall P. C. Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time. Curr Med Res Opin. 1977;5(1):21–25. doi: 10.1185/03007997709108971. [DOI] [PubMed] [Google Scholar]
  7. Chalmers T. M., Glass R. C., Risdall P. C. Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations. Curr Med Res Opin. 1977;5(1):17–20. doi: 10.1185/03007997709108970. [DOI] [PubMed] [Google Scholar]
  8. Collins A. J., Cosh J. A. Temperature and biochemical studies of joint inflammation. A preliminary investigation. Ann Rheum Dis. 1970 Jul;29(4):386–392. doi: 10.1136/ard.29.4.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  10. Dick W. C. The use of radioisotopes in normal and diseased joints. Semin Arthritis Rheum. 1972 Spring;1(4):301–325. doi: 10.1016/0049-0172(78)90007-0. [DOI] [PubMed] [Google Scholar]
  11. Dromgoole S. H., Furst D. E., Desiraju R. K., Nayak R. K., Kirschenbaum M. A., Paulus H. E. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis. Clin Pharmacol Ther. 1982 Sep;32(3):371–377. doi: 10.1038/clpt.1982.174. [DOI] [PubMed] [Google Scholar]
  12. Grennan D. M., Aarons L., Siddiqui M., Richards M., Thompson R., Higham C. Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br J Clin Pharmacol. 1983 Mar;15(3):311–316. doi: 10.1111/j.1365-2125.1983.tb01504.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grennan D. M. Histamine receptors in the synovial microcirculation. Eur J Clin Invest. 1975 Feb;5(1):75–82. doi: 10.1111/j.1365-2362.1975.tb00431.x. [DOI] [PubMed] [Google Scholar]
  14. Ray J. E., Wade D. N., Graham G. G., Day R. O. Pharmacokinetics of carprofen in plasma and synovial fluid. J Clin Pharmacol. 1979 Oct;19(10):635–643. doi: 10.1002/j.1552-4604.1979.tb01626.x. [DOI] [PubMed] [Google Scholar]
  15. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  16. Salisbury R. S., Parr G., De Silva M., Hazleman B. L., Page-Thomas D. P. Heat distribution over normal and abnormal joints: thermal pattern and quantification. Ann Rheum Dis. 1983 Oct;42(5):494–499. doi: 10.1136/ard.42.5.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sheiner L. B. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev. 1984;15(1-2):153–171. doi: 10.3109/03602538409015063. [DOI] [PubMed] [Google Scholar]
  18. Wallis W. J., Simkin P. A. Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics. Clin Pharmacokinet. 1983 Nov-Dec;8(6):496–522. doi: 10.2165/00003088-198308060-00002. [DOI] [PubMed] [Google Scholar]
  19. Wanwimolruk S., Brooks P. M., Birkett D. J. Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Br J Clin Pharmacol. 1983 Jan;15(1):91–94. doi: 10.1111/j.1365-2125.1983.tb01469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Whitlam J. B., Brown K. F., Crooks M. J., Room G. F. Transsynovial distribution of ibuprofen in arthritic patients. Clin Pharmacol Ther. 1981 Apr;29(4):487–492. doi: 10.1038/clpt.1981.67. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES